Targeted treatment and immunotherapy in older patients with advanced melanoma: A single institution real-life experience

被引：1
|
作者：
Pereira, C. [1 ]
Martins-Branco, D. [1 ]
Bexiga, C. Valente [1 ]
Monteiro, A. M. [1 ]
Nunes, H. [1 ]
Luis, A. [1 ]
Gouveia, E. [1 ]
Moreira, A. [1 ]
Passos, M. J. [1 ]
机构：
[1] Inst Portugues Oncol Lisboa Francisco Gentil EPE, Dept Med Oncol, Lisbon, Portugal
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1242
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1119P
引用
收藏
页码：S753 / S753
页数：1
相关论文
共 50 条
  • [1] Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
    Mangana, Joanna
    Cheng, Phil F.
    Kaufmann, Corina
    Amann, Valerie C.
    Frauchiger, Anna L.
    Stoegner, Viola
    Held, Ulrike
    von Moos, Roger
    Michielin, Olivier
    Braun, Ralph P.
    Levesque, Mitchell P.
    Goldinger, Simone M.
    Dummer, Reinhard
    MELANOMA RESEARCH, 2017, 27 (04) : 358 - 368
  • [2] Real World experience of immunotherapy and targeted therapies for treatment of Malignant Melanoma: A single centre experience
    Devine, T.
    Dennehy, C.
    Carty, K.
    Horgan, A.
    O'Connor, M.
    Jordan, M.
    Calvert, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S49 - S49
  • [3] Multi-center real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland
    Mangana, J.
    Amann, V. C.
    Goldinger, S. M.
    Kaufmann, C.
    Frauchiger, A. L.
    Cheng, P.
    Stoegner, V.
    Held, U.
    Von Moos, R.
    Romano, E.
    Michielin, O.
    Braun, R.
    Levesque, M. P.
    Dummer, R.
    MELANOMA RESEARCH, 2016, 26 : E41 - E42
  • [4] Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma
    Cécile Frenard
    Katleen Blanchet
    Philippe Lecerf
    Emilie Varey
    Amir Khammari
    Brigitte Dréno
    European Journal of Dermatology, 2023, 33 : 75 - 80
  • [5] Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma
    Frenard, Cecile
    Blanchet, Katleen
    Lecerf, Philippe
    Varey, Emilie
    Khammari, Amir
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (02) : 75 - 80
  • [6] Talimogene Laherparepvec for the Treatment of Advanced Melanoma : A Single Institution Experience
    Perez, M.
    Miura, J.
    Naqvi, S. H.
    Kim, Y.
    Holstein, A.
    Lee, D.
    Sarnaik, A. A.
    Zager, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S177 - S177
  • [7] Real-life experience of eribulin in patients with advanced liposarcoma
    Rodriguez Ramallo, H.
    Jimenez Galan, R.
    Baez Gutierrez, N.
    Flores Moreno, S.
    Abdelkader Martin, L.
    Vega Coca, M. D.
    Seisdedos Elcuaz, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S16 - S16
  • [8] Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
    Asher, Nethanel
    Israeli-Weller, Noa
    Shapira-Frommer, Ronnie
    Ben-Betzalel, Guy
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2021, 13 (12)
  • [9] Real-life experience with hazelnut oral immunotherapy
    Sabouraud, Marie
    Bierme, Priscille
    Andre-Gomez, Sylvie-Anne
    Villard-Truc, Florence
    Payot, Francois
    Correard, Anne-Karine
    Garnier, Lorna
    Braun, Camille
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 128 (04) : 432 - 438
  • [10] Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma
    Hou, Jing-Yu
    Xiao, Ya-ting
    Huang, Jing-Bo
    Jiang, Xin-Hua
    Jiang, Kai
    Li, Xun
    Xu, Li
    Chen, Min-Shan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
12345